Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012003 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Simon Syga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interdisciplinary Digital Sciences, Department Information Services and High Performance Computing, TUD Dresden University of Technology, …. Hauptthemen laut MEDLINE: Phenotype, Glioblastoma, Cell Proliferation, Tumor Microenvironment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Worldwide Cancer Research, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Cancer is a significant global health issue, with treatment challenges arising from intratumor heterogeneity. This heterogeneity stems mainly from somatic evolution, causing genetic diversity within the tumor, and phenotypic plasticity of tumor cells leading to reversible phenotypic changes. However, the interplay of both factors has not been rigorously investigated. Here, we examine the complex relationship between somatic evolution and phenotypic plasticity, explicitly focusing on the interplay between cell migration and proliferation. This type of phenotypic plasticity is essential in glioblastoma, the most aggressive form of brain tumor. We propose that somatic evolution alters the regulation of phenotypic plasticity in tumor cells, specifically the reaction to changes in the microenvironment. We study this hypothesis using a novel, spatially explicit model that tracks individual cells’ phenotypic and genetic states. We assume cells change between migratory and proliferative states controlled by inherited and mutation-driven genotypes and the cells’ microenvironment. We observe that cells at the tumor edge evolve to favor migration over proliferation and vice versa in the tumor bulk. Notably, different genetic configurations can result in this pattern of phenotypic heterogeneity. We analytically predict the outcome of the evolutionary process, showing that it depends on the tumor microenvironment. Synthetic tumors display varying levels of genetic and phenotypic heterogeneity, which we show are predictors of tumor recurrence time after treatment. Interestingly, higher phenotypic heterogeneity predicts poor treatment outcomes, unlike genetic heterogeneity. Our research offers a novel explanation for heterogeneous patterns of tumor recurrence in glioblastoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Interdisciplinary Digital Sciences, Department Information Services and High Performance Computing, TUD Dresden University of Technology, Dresden, Germany.
- Njord Centre, Department of Physics, University of Oslo, Oslo, Norway.
- School of Mathematics and Statistics, University of St Andrews, St Andrews, United Kingdom.
- Mathematics Department, Khalifa University, Abu Dhabi, United Arab Emirates.
ORCID-Profile: Simon Syga, Haralampos Hatzikirou
Förderung
- European Union
- Worldwide Cancer Research
- Bundesministerium für Bildung und Forschung
- European Research Council
- H2020 Marie Skłodowska-Curie Actions
- Volkswagen Foundation
- Khalifa University of Science, Technology and Research
- NIH-UAE collaborative call 2023
Zitieren
APA
Syga, S., Jain, H. P., Krellner, M., Hatzikirou, H., & Deutsch, A. (2024). Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012003
Vancouver
Syga S, Jain HP, Krellner M, Hatzikirou H, Deutsch A. Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012003
BibTeX
@article{Syga2024,
author = {Syga, Simon and Jain, Harish P and Krellner, Marcus and Hatzikirou, Haralampos and Deutsch, Andreas},
title = {Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012003}
}
EUVIMED